The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 2, 2004, Pages 266-269

  McGuigan, C ^a   Hutchinson, M ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMMUNITY; CONTROLLED STUDY; DETERIORATION; DISABILITY; FEMALE; HOSPITAL; HOSPITALIZATION; HUMAN; INVOLUTIONAL DEPRESSION; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS IMPACT SCALE; NEUROLOGY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 0842265944     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
2. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122:871-82.
3. Nunnally JC, Bernstein IH. Psychometric theory, 3rd edn. New York: McGraw-Hill, 1994.
4. Hobart J, Freeman J, Thompson A. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 2000;123:1027-40.
5. Sharrack B, Hughes RA, Soudain S, et al. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999;122:141-59.
6. Thompson A, Hobart JC. Multiple sclerosis: assessment of disability and disability scales. J Neurol 1998;245:189-96.
7. Kalkers NF, de Groot V, Lazeron RHC, et al. MS functional composite: relation to disease phenotype and disability strata. Neurology 2000;54:1233-9.
8. Cohen JA, Fischer JS, Bolibrush DM, et al. Intrarater and interrater variability of the MS functional composite outcome measure. Neurology 2000;54:802-6.
9. Vickrey BG, Hays RD, Harooni R, et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995;4:187-206.
10. Hobart J, Freeman J, Lamping D, et al. The SF-36 in multiple sclerosis: why basic assumptions must be tested. J Neurol Neurosurg Psychiatry 2001;71:363-70.
11. Peto V, Jenkinson C, Fitzpatrick R, et al. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-8.
12. Cella DF, Dineen K, Arnoson B, et al. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996;47:129-39.
13. LaRocca NG, Ritvo PG, Miller DM, et al. 'Quality of life' assessment in multiple sclerosis clinical trials: current status and strategies for improving multiple sclerosis clinical trial design. In: Goodkin DE, Rudick RA, eds. Multiple sclerosis: advances in clinical trial design, treatment and future perspectives. London: Springer-Verlag, 1996:145-60.
14. Sharrack B, Hughes RAC. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis. Mult Scler 1999;5:223-33.
15. Vickrey BG, Hays RD, Harooni R, et al. A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995;4:187-206.
16. Pfennings LE, Van der Ploeg HM, Cohen L, et al. A health-related quality of life questionnaire for multiple sclerosis patients. Acta Neurol Scand 1999;100:148-55.
17. Hobart J, Lamping D, Fitzpatrick R, et al. The multiple sclerosis impact scale (MSIS-29). A new patient-based outcome measure. Brain 2001;124:962-73.
18. Riazi A, Hobart J, Lamping D, et al. Multiple sclerosis impact scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 2002;73:701-4.
19. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
20. Harwood RH, Rogers A, Dickinson E, et al. Measuring handicap: the London handicap scale, a new outcome measure for chronic disease. Qual Health Care 1994;3(1):11-16.
21. Robinson BE, Kelley L. Concurrent validity of the Beck Depression Inventory as a measure of depression. Psychol Rep 1996;79:929-30.
22. Staquet MJ, Hays RD, Foyers PM. Quality of life assessment in clinical trials: methods and practice, 1st edn. Oxford: Oxford University Press, 1998.
23. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press, 1960.
24. Kaziz LE, Anderson JJ, Meenan RF. Effect sizes for determining changes in health status. Med Care 1989;27:S178-89.
25. Hoogervorst ELJ, Eikelenboom MJ, Uitehaag BMJ, et al. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry 2003;74:439-42.